Seed Oils and Inflammation: Is There a Real Connection?

The claim that seed oils cause inflammation appears in everything from peer-reviewed biochemistry papers to viral social media posts. But like most nutrition controversies, the full picture is more nuanced than either side typically acknowledges. Here is what the evidence actually shows.

What Is Chronic Inflammation?

Before examining the seed oil connection, it helps to understand what chronic inflammation actually is.

Inflammation is a normal, necessary biological process. When you cut your finger, bacteria invade, or a pathogen enters the body, the immune system mounts an acute inflammatory response — blood vessels dilate, white blood cells rush in, and the area becomes red, warm, and swollen. Within days, the threat is neutralised and inflammation resolves.

Chronic inflammation is different. It is a persistent, low-grade activation of the same inflammatory machinery, occurring without an obvious acute threat, and not fully resolving. It is associated with elevated circulating levels of inflammatory markers — particularly C-reactive protein (CRP), interleukin-6 (IL-6), and tumour necrosis factor-alpha (TNF-α).

Chronic inflammation is implicated in — and likely causal in — multiple serious diseases:

• Cardiovascular disease (atherosclerosis involves inflammatory processes)
• Type 2 diabetes (inflammatory cytokines impair insulin signalling)
• Non-alcoholic fatty liver disease
• Rheumatoid arthritis and other autoimmune conditions
• Certain cancers
• Neurodegenerative conditions including Alzheimer's disease

The question is whether dietary seed oils contribute to this chronic inflammatory state.

How Seed Oils Might Drive Inflammation

The biochemical mechanism is plausible and well-documented, even if its real-world magnitude is debated.

The Linoleic Acid Pathway

Linoleic acid (LA) — the primary omega-6 fatty acid in seed oils — is not intrinsically inflammatory. The pathway proceeds as follows:

1. LA is consumed via cooking oils, packaged foods, and restaurant meals
2. LA is converted (via delta-6-desaturase enzyme) to gamma-linolenic acid (GLA), then to dihomo-GLA (DGLA), then to arachidonic acid (AA)
3. AA is incorporated into cell membrane phospholipids
4. When cells are stressed or activated, AA is released from membranes by phospholipase A2
5. Released AA is metabolised by cyclooxygenase (COX) enzymes to produce prostaglandins and thromboxanes, or by lipoxygenase (LOX) enzymes to produce leukotrienes
6. The resulting eicosanoids include pro-inflammatory molecules: prostaglandin E2 (PGE2), thromboxane A2 (TXA2), and leukotriene B4 (LTB4)

Now here is where omega-3 becomes critical to the story: EPA (eicosapentaenoic acid, from fish and fish oil) competes with AA for the exact same COX and LOX enzymes. When EPA is present at the enzyme active site instead of AA, it produces eicosanoids with anti-inflammatory or neutral properties — including prostaglandin E3 (weakly inflammatory), thromboxane A3 (weakly aggregatory), and leukotriene B5 (weakly inflammatory).

The omega-6:omega-3 ratio in your diet therefore directly influences which substrate wins the enzymatic competition, and consequently which type of eicosanoids are produced in greater quantities.

What the Evidence Shows

The Simopoulos (2002) Research

The most cited evidence for the ratio model comes from Artemis Simopoulos's review in Biomedicine & Pharmacotherapy. Simopoulos documented associations between lower omega-6:omega-3 ratios and:

• Reduced total mortality in cardiovascular disease patients (70% reduction at a ratio of 4:1 vs higher ratios — from the Lyon Diet Heart Study)
• Reduced inflammatory markers in multiple observational studies
• Lower rates of autoimmune and inflammatory conditions in populations with lower ratios (Mediterranean, Japanese)

The Lyon Diet Heart Study

This randomised trial (de Lorgeril et al., 1999) assigned patients who had survived a myocardial infarction to either a Mediterranean-style diet or a standard post-infarction diet. The Mediterranean group consumed more alpha-linolenic acid (plant omega-3) and oleic acid (olive oil), and substantially less linoleic acid. After a mean follow-up of 27 months, the Mediterranean group had a 72% reduction in cardiac death and non-fatal infarction — a striking result.

Elevated AA-Derived Eicosanoids and Disease

Research consistently shows that populations and individuals with higher omega-6:omega-3 ratios have higher circulating levels of arachidonic acid metabolites — thromboxane B2, leukotriene B4, and prostaglandin E2. These are associated with increased platelet aggregation, arterial inflammation, and immune over-activation.

The Other Side: Legitimate Counterarguments

A complete picture requires acknowledging genuine scientific disagreement.

The absolute vs relative intake argument: Some researchers argue that the observed harms in high-omega-6 diets are primarily due to simultaneously low omega-3 intake, not high omega-6 per se. Under this view, simply increasing omega-3 intake without reducing omega-6 is equally effective.

RCT evidence for replacing saturated fat with PUFA: Multiple randomised controlled trials have shown that replacing saturated fat with polyunsaturated fat (which includes omega-6) reduces LDL cholesterol and cardiovascular events. The Women's Health Initiative, MRFIT, and other trials support this relationship. This does not contradict the ratio model but complicates the "reduce omega-6" narrative.

Limited conversion of LA to AA: Some researchers argue that dietary linoleic acid does not substantially elevate tissue arachidonic acid at typical intake levels, because the delta-6-desaturase step is rate-limited. The evidence here is mixed.

Confounding: High omega-6 diets in the real world are almost always diets high in ultra-processed food — which is simultaneously high in refined carbohydrates, artificial additives, and low in fibre, micronutrients, and omega-3. It is genuinely difficult to separate the effects of seed oil omega-6 from other features of ultra-processed diets.

What Is Actually Agreed Upon

Despite the controversy, several positions represent genuine consensus:

1. The omega-6:omega-3 ratio influences the balance of pro- and anti-inflammatory eicosanoids — this is established biochemistry
2. Increasing EPA/DHA omega-3 intake reduces inflammatory markers — well supported by multiple RCTs
3. The modern Western dietary ratio (15–25:1) is far higher than the ratio associated with optimal health in observational studies (4:1)
4. Reducing ultra-processed food consumption (which is the primary source of dietary seed oil for most people) improves health outcomes across multiple dimensions
5. The inflammatory properties of omega-6 depend critically on the concurrent omega-3 intake

The Practical Implication

You don't need to resolve the academic debate to make sensible dietary decisions. The practical implications are the same regardless of whether the primary mechanism is:

a) Seed oil omega-6 directly producing AA-derived pro-inflammatory eicosanoids b) Seed oil omega-6 displacing omega-3 from enzymatic pathways c) Seed oils being a marker for ultra-processed food consumption generally

In all three cases, the rational response is the same:

• Cook with olive oil, avocado oil, or butter instead of seed oils
• Eat oily fish 2–3 times per week
• Reduce packaged and fried foods
• Consider an omega-3 supplement if fish intake is low

These changes improve the omega-6:omega-3 ratio, reduce ultra-processed food intake, and increase EPA/DHA. Whether the benefit comes primarily from reducing inflammation, improving eicosanoid balance, or both, the net effect is the same.